Skip to content

Online intervention to enhance confidence to manage problems associated with cancer related fatigue following primary cancer treatment

RESTORE: An exploratory randomised controlled trial of an online intervention to enhance confidence to manage problems associated with cancer related fatigue following primary cancer treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN67521059
Enrollment
125
Registered
2012-10-05
Start date
2012-09-13
Completion date
Unknown
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: National Cancer Research Network

Interventions

Participants who use online resource (RESTORE) will be compared with those receiving a booklet
Macmillan Cancer backup ?Coping with Fatigue? Online intervention to enhance self-efficacy (confidence) to manage problems associated with cancer-related fatigue following primary can

Sponsors

Southampton University Hospitals NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Have had a clinical diagnosis of invasive cancer within the last 5 years 2. Have completed or are nearing complement of treatment (surgery/chemotherapy/ radiotherapy) with curative intent 3. Have no evidence of metastatic disease 4. Aged 18+, no upper age limit 5. Are experiencing fatigue: defined as scoring = 4 on a unidimensional 11-point numeric rating scale (NRS) for fatigue as suggested by the National Comprehensive Cancer Network and/or have low self-efficacy to manage their fatigue <4 on a unidimensional 10 point rating scale. 6. Able to complete written records in English 7. Have access to the internet ? at home, from a community resource such as a library or through patients information services linked to health services e.g. Macmillan information services 8. Have or are willing to create an email account

Exclusion criteria

Exclusion criteria: 1. In the opinion of a relevant clinician they are unable to give informed consent (e.g. due to severe cognitive impairment or learning disability) 2. Are too ill to engage in the intervention 3. The intervention will be developed and tested in the English language this means that non-English speakers will be excluded from this study. We would hope to be able to make the intervention accessible in a number of languages once testing is complete and we have established effectiveness.

Design outcomes

Primary

MeasureTime frame
Test the value (provide ?proof of concept?) of the intervention, measured using questionnaire (validated method) which is completed by the participants

Secondary

MeasureTime frame
No secondary outcome measures

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 23, 2026